Allied Market Research

2024

Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Product and by Technology : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Autoimmune diseases refer to a bodys abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. There are almost 80 types of autoimmune diseases prevailing worldwide including systemic lupus erythematosus or rheumatoid arthritis. According to the estimation by American Autoimmune Related Diseases Association (AARDA), autoimmune disease affects up to 50 million Americans and 75% of them are females. The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate.

The global autoimmune disease diagnostics market is driven by improved laboratory techniques and automation, growth in public awareness for autoimmune disorders, rise in partnerships between physicians and clinical laboratories, increase in incidence of diseases such as rheumatoid arthritis and Graves and Hashimoto's Thyroid Disease. However, high frequency of false positive results and slow turnaround time for diagnostic test results restrain the market growth. Rapid technological advancements in medical field such as novel biomarkers, rise in healthcare expenditure, development of the emerging markets, and favorable government initiatives is expected to offer lucrative opportunities for the growth of the market.

This global market is segmented on the basis of type, product, service, technology, and region. Based on type, it is bifurcated into localized autoimmune disease diagnostic and systemic autoimmune disease diagnostic. Based on product, it is divided into drugs, therapeutic & monitoring equipment, and diagnostic equipment. Based on technology, it is divided into bridge therapy, disease-modifying antirheumatic drugs (DMARD), topical therapy, phototherapy, helminthic therapy, and recombinant technology. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market are AstraZeneca, F. Hoffmann-La Roche, Novartis AG, Pfizer Inc., Sanofi-aventis, Abbott Laboratories, Beckman Coulter Inc., Inova Diagnostics Inc., Bio-Rad Laboratories Inc., and Hemagen Diagnostics Inc.

Key Benefits

  • The study provides an in-depth analysis of the global autoimmune disease diagnostic market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market by product assists to understand the various forms of autoimmune disease diagnostic available.
  • Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

Autoimmune Disease Diagnostics Market Report Highlights

Aspects Details
icon_5
By Type
  • Localized Autoimmune Disease Diagnostic
  • Systemic Autoimmune Disease Diagnostic
icon_6
By Product
  • Drugs
  • Therapeutic & Monitoring Equipment
  • Diagnostic Equipment
icon_7
By Technology
  • Bridge Therapy
  • Disease-modifying Antirheumatic Drugs (DMARD)
  • Topical Therapy
  • Phototherapy
  • Helminthic Therapy
  • Recombinant Technology
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_9
Key Market Players

Abbott Laboratories, Novartis AG, Inova Diagnostics Inc., F. Hoffmann-La Roche, Sanofi-Aventis, Hemagen Diagnostics Inc., Bio-Rad Laboratories Inc., Beckman Coulter Inc., Pfizer Inc., AstraZeneca

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Autoimmune Disease Diagnostics Market

Global Opportunity Analysis and Industry Forecast, 2023-2032